DREAMM13

A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function

Near Add Your Location

Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
  • Not yet accepting
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
UPMC Hillman Cancer Center
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, PA
  • Accepting patients
  • Show Principal Investigator
  • Not yet accepting
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
Baylor Charles A. Sammons Cancer Center
Baylor Scott & White Health
Dallas, TX
  • Not yet accepting
  • Show Principal Investigator
University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
  • Accepting patients
  • Show Principal Investigator
Sarah Cannon Research Institute at Tennessee Oncology
TriStar Centennial Medical Center
Nashville, TN
  • Not yet accepting
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.